Reproducible Abnormalities and Diagnostic Generalizability of White Matter in Alzheimer's Disease

Neurosci Bull. 2023 Oct;39(10):1533-1543. doi: 10.1007/s12264-023-01041-w. Epub 2023 Apr 4.

Abstract

Alzheimer's disease (AD) is associated with the impairment of white matter (WM) tracts. The current study aimed to verify the utility of WM as the neuroimaging marker of AD with multisite diffusion tensor imaging datasets [321 patients with AD, 265 patients with mild cognitive impairment (MCI), 279 normal controls (NC)], a unified pipeline, and independent site cross-validation. Automated fiber quantification was used to extract diffusion profiles along tracts. Random-effects meta-analyses showed a reproducible degeneration pattern in which fractional anisotropy significantly decreased in the AD and MCI groups compared with NC. Machine learning models using tract-based features showed good generalizability among independent site cross-validation. The diffusion metrics of the altered regions and the AD probability predicted by the models were highly correlated with cognitive ability in the AD and MCI groups. We highlighted the reproducibility and generalizability of the degeneration pattern of WM tracts in AD.

Keywords: Alzheimer’s disease; Cross-validation; Diffusion tensor imaging; White matter tracts.

MeSH terms

  • Alzheimer Disease* / complications
  • Alzheimer Disease* / diagnostic imaging
  • Brain / diagnostic imaging
  • Cognition
  • Cognitive Dysfunction* / complications
  • Cognitive Dysfunction* / diagnostic imaging
  • Diffusion Tensor Imaging / methods
  • Humans
  • Reproducibility of Results
  • White Matter* / diagnostic imaging